We analyzed determinants of REE in patients with obesity and assessed UCP1 expression as a “brite” marker in abdominal subcutaneous AT (SAT) and visceral omental AT (VAT). Here, UCP1 is linked to obesity due to melanocortin 4 receptor deficiency.